Sign In
Buy ELAN
$23.18
-0.710 (-2.97%)
At Close: Jun 23, 2026
Elanco (ELAN) Hit with Investor Lawsuit Over New Drug – Hagens Berman
04:27pm, Thursday, 07'th Nov 2024
SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- A federal lawsuit has been filed in the U.S. District Court of Maryland against Elanco Animal Health Inc. and specific executives, accusing them of mak
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Did Elanco Animal Health (ELAN) Commit Securities Fraud Resulting in 21% Stock Drop? Contact BFA Law about the Class Action Lawsuit
03:47pm, Thursday, 07'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Elanco Lawsuit – ELAN
01:26pm, Thursday, 07'th Nov 2024
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) of a class action securities lawsuit.
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal se
Elanco Animal Health Incorporated (ELAN) Q3 2024 Earnings Call Transcript
11:09am, Thursday, 07'th Nov 2024
Elanco Animal Health Incorporated (NYSE:ELAN ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Katy Grissom - Head, Investor Relations Jeff Simmons - President & CEO
The Schall Law Firm Invites Shareholders To Join A Case Against Elanco Animal Health Incorporated For Securities Law Violations
11:00am, Thursday, 07'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elanco Animal Health Incorpora
Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics
10:35am, Thursday, 07'th Nov 2024
Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Elanco Animal Health Incorporated (ELAN) Shareholders
09:45am, Thursday, 07'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal se
INVESTOR REMINDER: Berger Montague Notifies Elanco Animal Health (NYSE: ELAN) Investors of a Class Action Lawsuit and Deadline
09:30am, Thursday, 07'th Nov 2024
PHILADELPHIA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Elanco Animal Health Inc. (“Elanco” or the “Company”) (NYSE: ELAN). The lawsuit has bee
Elanco Animal Health Incorporated (ELAN) Q3 Earnings Top Estimates
08:35am, Thursday, 07'th Nov 2024
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.18 per share a ye
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elanco Animal
December 6, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - ELAN
06:45am, Thursday, 07'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal se
Elanco Animal Health Reports Third Quarter 2024 Results
06:27am, Thursday, 07'th Nov 2024
Third Quarter 2024 Financial Results Revenue of $1,030 million, organic constant currency growth of 1% Reported Net Income of $364 million, Adjusted Net Income of $66 million Adjusted EBITDA of $163 m
